| Name | Title | Contact Details |
|---|---|---|
Carrie Loeffler |
Human Resources Director | Profile |
OrthoFX have the best materials technology in the industry, due in large part to Loc Phan, the key scientist behind developing the first ever clear aligner. We are committed to continued polymer technology innovation by hiring a team of industry experts like Loc to understand your needs and pain points, and we can`t do it without your partnership.
Welcome to the Alliance for Positive Health! We are a community based organization dedicated to improving lives impacted by HIV/AIDS and other chronic illnesses. For over 30 years the Alliance for Positive Health has modeled client centered care and provided skills to help those we serve make informed decisions. Please explore this website to find out about the wide range of support, services and interventions we provide to improve the health of our community. At the Alliance for Positive Health, we work with those who face barriers to accessing health care and social services and strive to reduce health disparities. Our clients` diagnoses are often complicated by stigma, addiction, poverty, homelessness, incarceration or mental illness – and these are the factors which also place them at risk infection with HIV, Hepatitis C and other Sexually Transmitted Diseases.
Argentum is the leading national trade association serving companies that own, operate, and support professionally managed senior living communities in the United States.
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
Rush-Copley Medical Center, Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Aurora, IL. To find more information about Rush-Copley Medical Center, Inc, please visit www.rushcopley.com